Artwork
iconShare
 
Manage episode 480976604 series 2902118
Content provided by ACCP JOURNALS. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ACCP JOURNALS or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

The authors evaluate the efficacy and safety of emerging therapeutic strategies for CKD management, including sodium-glucose cotransporter 2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP-1RA), finerenone, sacubitril/valsartan, and potassium binders. Read the full text manuscript at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.70014.

  continue reading

162 episodes